MCCS publishes ‘broader’ cannabis prescription guidelines

The Medical Cannabis Clinicians’ Society (MCCS) and the All-Party Parliamentary Group (APPG) for Medical Cannabis under Prescription issued new guidance last week identifying conditions for which there are “conclusive or substantial”, “moderate”, and “limited” evidence of efficacy of medical cannabis treatment, as well as those for which it says there is “no conclusive evidence”. Mike […]

Continue Reading

GDNF protein Parkinson’s treatment ‘extremely promising’

A trial has found that an experimental drug called GDNF could offer hope for restoring damaged brain cells in Parkinson’s patients. Scientists said some brain scans revealed “extremely promising” effects on damaged neurons after the protein therapy was delivered directly into the brains of Parkinson’s patients. Glial Cell Line Derived Neurotrophic Factor (GDNF) is a […]

Continue Reading